National Bank Of Canada Pds Biotechnology Corp Transaction History
National Bank Of Canada
- $72.7 Billion
- Q3 2024
A detailed history of National Bank Of Canada transactions in Pds Biotechnology Corp stock. As of the latest transaction made, National Bank Of Canada holds 1 shares of PDSB stock, worth $1. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$1
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.32MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$793,7560.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$676,6340.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$561,3620.18% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$381,7600.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $46.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...